- Biomarkers for Invasive Mucormycosis
- COVID-19 and Rhino-orbital Mucormycosis
- COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital
- Evaluation of Using 3D Printed PEEK Facial Implants in Repairing Maxillofacial Deformities
- Mucormycosis in ICU
- Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran
- Patterns of Real-World Isavuconazole Use – a Study of Patients With Mucormycosis or Invasive Aspergillosis
- Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment
- Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
- Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis
- The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study
Clinical Trials
- A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy
- A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy
- A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)
- A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
- Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
- Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing
- Effect of Resistance and Aerobic Exercise in CIDP or MMN
- Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)
- HyQvia in Multifocal Motor Neuropathy
- Immunoglobulin Dosage and Administration Form in CIDP and MMN
- Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.
- Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy
- Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
- Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
- Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
- Safety Study of Live Attenuated Mumps Vaccines in Junior High School Students Under 14 Years Old
- Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)
- A Multicenter Prospective Registration Study of Myasthenic Crisis in China
- A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)
- A Phase II Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis
- A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis
- A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis
- A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)
- A Prospective Cohort Study Of Myasthenia Gravis
- A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal Disease
- A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- A Study of RVT-1401 in Myasthenia Gravis (MG) Patients
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis
- A Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Participants With Generalized Myasthenia Gravis
- A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients
- A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
- A Study to Evaluate Thefficacy and Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized MG Patients
- A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
- A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
- Acupuncture in Myasthenia Gravis (AcuMG)
- An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
- Association Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese Population
- BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis
- Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis
- Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis
- Burden of Disease in Myasthenia Gravis
- Can Interval Walking Influence on Fatigue in the Danish Cohort of Myasthenia Gravis Patients
- Clinical Prognosis and Progression of Myasthenia Gravis Patients
- Clinical Trial to Improve the Magnetic Levator Prosthesis
- Descriptive Analysis of Real-world Data Collected With ME&MGopen
- Diaphragm Thickness by Ultrasonography in Neurological Disorders
- Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis
- Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
- Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis
- Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis
- Efficacy of Methotrexate in Myasthenia Gravis
- Efficacy of Prednisone In the Treatment of Ocular Myasthenia
- Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis
- Exercise for Stable Myasthenia Gravis
- Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes
- Expression Levels of Interleukin37 and Its Correlation With Autoantibodies in Myasthenia Gravis.
- FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients
- Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection
- Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares
- Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
- Immune Profiles in Myasthenia Gravis
- Influence of Minimally Invasive Thymectomy on the Subsequent Clinical Course of Myasthenia Gravis
- Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective Study
- Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
- Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis
- Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis
- Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)
- Myasthenia Gravis and Psyche
- Myasthenia Gravis Inebilizumab Trial
- Mycophenolate Mofetil in Myasthenia Gravis
- Neurology Inpatient Clinical Education Trial
- Ocular Mysathenia Gravis Generalization
- Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
- Open-label Study to Determine the Maximum Tolerated Dose of MuSK-CAART for MuSK Myasthenia Gravis
- OVEMP in Myasthenia
- Oxaloacetate in Myasthenia Gravis
- Perception and Multisensory Integration in Neurological Patients Using fMRI
- Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis
- Physical Activity and Fatigue in Myasthenia Gravis
- Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
- Predictors and Prognostic Factors of Myasthenia Gravis Outcome
- Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
- Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk Test
- Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
- Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
- Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis
- Sensitivity of Repetitive Nerve Stimulation Performed in the Evening vs in the Morning in Myasthenia Gravis
- SP Thoracic IDE Study
- Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis
- Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis
- Study on Correlation Between Cytomegalovirus and Ocular Myasthenia Gravis
- Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis.
- Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis
- Subcutaneous Immunoglobulin for Myasthenia Gravis
- Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis
- The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum
- The Effect of Spinal Stabilization Exercises in Patients With Myasthenia Gravis
- The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
- The Evaluation of Belimumab in Myasthenia Gravis (MG)
- The EXPLORE MG Registry for Myasthenia Gravis
- The Impact of Myasthenia Gravis in the Real World
- The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
- The Role of the Thymus in Myasthenia Gravis
- The Safety and Efficacy of “3-Hole” Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor
- The Specificity, Sensitivity and Clinical Correlation of CBA, CBA-TSA, RIPA and ELISA Assay in Detecting AChR and MuSK IgG
- TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
- Therapeutic Plasma Exchange in MG
- Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
- Tissue Repository for Studies of Myasthenia Gravis
- Translation, Cross-cultural Adaptation and Validation of the MGQOL-15-F
- Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis
- Trial of Orencia in Patients With Myasthenia Gravis
- Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis
- A Multicenter Prospective Registration Study of Myasthenic Crisis in China
- A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)
- A Phase II Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis
- A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis
- A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis
- A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)
- A Prospective Cohort Study Of Myasthenia Gravis
- A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal Disease
- A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- A Study of RVT-1401 in Myasthenia Gravis (MG) Patients
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis
- A Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Participants With Generalized Myasthenia Gravis
- A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients
- A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
- A Study to Evaluate Thefficacy and Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized MG Patients
- A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
- A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
- Acupuncture in Myasthenia Gravis (AcuMG)
- An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
- Association Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese Population
- BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis
- Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis
- Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis
- Burden of Disease in Myasthenia Gravis
- Can Interval Walking Influence on Fatigue in the Danish Cohort of Myasthenia Gravis Patients
- Clinical Prognosis and Progression of Myasthenia Gravis Patients
- Clinical Trial to Improve the Magnetic Levator Prosthesis
- Descriptive Analysis of Real-world Data Collected With ME&MGopen
- Diaphragm Thickness by Ultrasonography in Neurological Disorders
- Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis
- Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
- Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis
- Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis
- Efficacy of Methotrexate in Myasthenia Gravis
- Efficacy of Prednisone In the Treatment of Ocular Myasthenia
- Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis
- Exercise for Stable Myasthenia Gravis
- Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes
- Expression Levels of Interleukin37 and Its Correlation With Autoantibodies in Myasthenia Gravis.
- FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients
- Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection
- Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares
- Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
- Immune Profiles in Myasthenia Gravis
- Influence of Minimally Invasive Thymectomy on the Subsequent Clinical Course of Myasthenia Gravis
- Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective Study
- Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
- Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis
- Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis
- Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)
- Myasthenia Gravis and Psyche
- Myasthenia Gravis Inebilizumab Trial
- Mycophenolate Mofetil in Myasthenia Gravis
- Neurology Inpatient Clinical Education Trial
- Ocular Mysathenia Gravis Generalization
- Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
- Open-label Study to Determine the Maximum Tolerated Dose of MuSK-CAART for MuSK Myasthenia Gravis
- OVEMP in Myasthenia
- Oxaloacetate in Myasthenia Gravis
- Perception and Multisensory Integration in Neurological Patients Using fMRI
- Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis
- Physical Activity and Fatigue in Myasthenia Gravis
- Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
- Predictors and Prognostic Factors of Myasthenia Gravis Outcome
- Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
- Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk Test
- Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
- Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
- Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis
- Sensitivity of Repetitive Nerve Stimulation Performed in the Evening vs in the Morning in Myasthenia Gravis
- SP Thoracic IDE Study
- Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis
- Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis
- Study on Correlation Between Cytomegalovirus and Ocular Myasthenia Gravis
- Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis.
- Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis
- Subcutaneous Immunoglobulin for Myasthenia Gravis
- Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis
- The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum
- The Effect of Spinal Stabilization Exercises in Patients With Myasthenia Gravis
- The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
- The Evaluation of Belimumab in Myasthenia Gravis (MG)
- The EXPLORE MG Registry for Myasthenia Gravis
- The Impact of Myasthenia Gravis in the Real World
- The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
- The Role of the Thymus in Myasthenia Gravis
- The Safety and Efficacy of “3-Hole” Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor
- The Specificity, Sensitivity and Clinical Correlation of CBA, CBA-TSA, RIPA and ELISA Assay in Detecting AChR and MuSK IgG
- TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
- Therapeutic Plasma Exchange in MG
- Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
- Tissue Repository for Studies of Myasthenia Gravis
- Translation, Cross-cultural Adaptation and Validation of the MGQOL-15-F
- Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis
- Trial of Orencia in Patients With Myasthenia Gravis
- Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis
- A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc
- A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF Patients
- Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)
- CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
- Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)
- Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
- Early Bactericidal Activity of Standard Drugs Used to Treat Mycobacterium Avium Complex: a Pilot Study
- Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease
- Improving Tolerance of Treatment of Pulmonary MAC Infections
- Phase 2a Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease
- RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease
- Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease
- Detection of Mycoplasma Pneumoniae
- Etiology of Community Acquired Pneumonia
- Evaluation of Pathogenesis and Diagnosis of Mycoplasma Pneumoniae Community-acquired Pneumonia (CAP)
- Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis
- Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting
- The Optimization of Mycoplasm Pneumonia Antibiotic Therapy
- 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes
- A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis
- A Study of BGB-11417 in Participants With Myeloid Malignancies
- A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
- Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
- Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes
- Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
- Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
- Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
- Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
- Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- Cholecalciferol in Treating Patients With Myelodysplastic Syndrome
- Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
- CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Blood Cancer Undergoing Donor Stem Cell Transplant
- Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
- Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome
- Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
- Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia
- Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
- Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
- Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
- Italian Network MDS Registry
- Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer
- Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma
- PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia
- Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant
- Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid Leukemia
- S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
- S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
- Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
- Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia
- T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia
- Tagraxofusp and Decitabine for the Treatment of Chronic Myelomonocytic Leukemia
- Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
- Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
- Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
- VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
- WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome